How MQ's board works
MQ Trustees form the governing body of the charity and are accountable for management and trustworthiness of the charity as it performs its work for public benefit. Trustees serve a term of three years (renewable once) and the current MQ board is made up of experts in law, management, finance, fundraising, publishing and research.
Trustees are recruited for their professional expertise and personal interest and experience of mental health issues. This helps to ensure that the Board acts in the best interest of the charity, manages resources responsibly and works toward our mission with understanding, skill and care.
Sir Philip Campbell
Philip is Editor-in-Chief of Nature and of the Nature Publishing Group. His areas of responsibility include the editorial content and management of Nature, and assuring the long-term quality of all Nature publications. He is based in London.
He has a BSc in aeronautical engineering, an MSc in astrophysics and a PhD and postdoctoral research in upper atmospheric physics. Following his research, he became the Physical Sciences Editor of Nature and then, in 1988, the founding editor of Physics World, the international magazine of the UK Institute of Physics. He returned to Nature to take on his current role in 1995.
He has worked with the UK government, the European Commission and the US National Institutes of Health on issues relating to science and its impacts in society. For ten years until 2012 he was a trustee of Cancer Research UK. He was a founding trustee of MQ before being elected Chair in 2015. He is an elected Fellow of the Royal Astronomical Society and of the Institute of Physics, has honorary degrees from several universities, and was awarded an Honorary Professorship by the Peking Union Medical College. He is a Life Member of Clare Hall, University of Cambridge. He was awarded a knighthood in the Queen’s birthday honours list of 2015 for his services to science.
Dr. Arash Hejazi
Arash is the Editorial Director of journals in social sciences and humanities at Wiley and Sons Inc. In his previous roles he was the Publisher of The Pharmaceutical Journal by the Royal Pharmaceutical Society and the associate publisher of Nature, where he was heavily involved in product development, product management, publishing and editorial strategic planning.
Arash Hejazi received his doctorate in medicine in 1996 from the Iran University of Medical Sciences, before launching his publishing house Caravan in 1997, the magazines Kamyaab in 2000 and Book Fiesta in 2003. In 2006 he was nominated to receive the Freedom to Publish award from the International Publishers’ Association.
He is also a novel writer, whose best known novel The Princess of the Land of Eternity was shortlisted for two major Iranian literary prizes and has sold more than 20,000 copies in Iran since its first publication in 2003. His dissertation for his MA in Publishing from Oxford Brookes University on censorship in Iran was published in the publishing journal Logos in 2011, and his memoir The Gaze of the Gazelle about growing up in Iran after the Islamic Revolution was published in 2011.
John has more than 40 years of experience as an investment banker, advising mainly on mergers and acquisitions during a long career at Lehman Brothers, JP Morgan and Lincoln International. He serves or has served on a large number of US based charity Boards including National Public Radio, The Jewish Board of Family and Children’s Services, The U.S. Fund for UNICEF, UJA/Federation of New York and The Yale School of Music in various leadership capacities. In addition, he is a Director of a number of corporations. He holds a Master of Business Administration degree from the Harvard University Graduate School of Business and a Bachelor of Arts Degree from Yale College. He lives in New York City, U.S.A.
Professor Emily Holmes
Emily is the Programme Leader at the MRC Cognition and Brain Sciences Unit in Cambridge. She is also Guest Professor in Clinical Psychology at Karolinska Institutet in Sweden, Honorary Professor in Psychiatry at the University of Oxford, and a Wellcome Trust Clinical Fellow. She is a Fellow of Clare Hall, University of Cambridge, and a practicing clinical psychologist.
Within mental health science, her field is experimental psychopathology for psychological treatment innovation. Linking cognitive science with clinical psychology, psychiatry and neuroscience her team’s research focuses on trauma and mood disorders, with a particular interest in mental imagery and emotion.
She is Associate Editor of “Clinical Psychological Science”. Her research has been recognised by the British Psychological Society’s Spearman Medal (2010), Humboldt Foundation Friedrich Wilhelm Bessel Research Award (2013), and the American Psychological Association (2014).
Professor Peter Jones
Peter is Professor of Psychiatry & Head of the Department of Psychiatry at the University of Cambridge. He is a board member of Cambridge University Health Partners and directs the NIHR Collaboration for Leadership in Applied Health Research & Care (CLAHRC) East of England.
Peter’s research concerns the epidemiology of mental illness, particularly the psychoses, early life course influences on adult mental health and illness, and the interface between population-based and biological investigations and explanations, including genetics. He also works in treatment research with randomised trials of drug and psychological treatments for psychotic illness.
Clinically, Peter works as an honorary consultant to CAMEO, the Cambridgeshire & Peterborough Foundation Trust’s early intervention service for young people with first episode psychosis.
Peter has been a non-executive director of a specialist mental health NHS trust (2001-2005), served as a co-opted expert on the Advisory Council on the Misuse of Drugs consideration of the legal status of cannabis (2005 & 2008) and coordinates the Royal College of Psychiatrists Early Intervention Network. He became a NIHR Senior Investigator in 2010.
In over a decade of venture investing at Advent, Shahzad has been actively involved with numerous successful investments in Europe and the US in the biopharmaceutical, medical device, and diagnostics arenas. These include Algeta, Respivert, Biocartis, Powdermed and Versartis.
Shahzad came to Advent in 1999 with a strong background in science and clinical medicine. He gained invaluable experience at the London office of McKinsey & Company serving international clients in the Healthcare and Investment Banking sectors.
Shahzad gained an MA in Physiological Sciences while at Oxford University and an MD from Cambridge University. He then specialised in interventional cardiology while at the same time pursuing research interests in heart muscle disorders, both in the clinic and basic science laboratory.
Clare Matterson, CBE
Clare Matterson CBE is an adviser to major global foundations and a non-executive Board member. After 18 years at Wellcome, she is focussing on a smaller number of projects that have the potential to make a real difference at a global, national or local level. These include being a Special Adviser to Wellcome's Our Planet Our Health strategic initiative, a member of the World Economic Forum's Future Global Council on Food, Agriculture & Nutrition and adviser and Vice Chair of the EAT Foundation to create health & sustainable diets for all.
With a strong strategic, creative streak and the ability to build teams and make things happen, Clare led many of Wellcome's transformative initiatives, including being one of the founders of Wellcome Collection and establishing the UK's National STEM Learning Centre.
Clare is Chair of the UK National STEM Forum for Public Engagement, a Trustee for the wonderful Horniman Museum and a Board member for the inspiring Flipside Festival in East Anglia and the incredible Science Gallery International.
Clare was awarded a CBE for services to public engagement in 2015, a Fellowship to the British Science Association for outstanding contributions to public engagement and was one of GQ's top 100 influential women in 2015.
Dr Helen Munn
Helen is the Executive Director of the Academy of Medical Sciences – the UK’s national academy representing the full spectrum of medical science, from basic research through clinical application to healthcare delivery. The Academy’s 1200 elected Fellows are the UK’s most talented biomedical and health researchers, working to promote medical science and its translation into benefits for society.
Helen joined the Academy’s policy team in 2004, becoming Executive Director in 2009. Since then she has overseen a major expansion in the Academy’s resources, profile and impact, including a successful £5 million fundraising appeal to establish the Academy’s first headquarters in 2010, influential policy reports, leading-edge public dialogue exercises, and a portfolio of innovative grant and mentoring schemes to support early career researchers in the UK and overseas.
Prior to joining the Academy, Helen completed a fellowship at UK Parliamentary Office for Science & Technology and worked for a short time in the BBC Science Team. She followed her undergraduate degree from The Queen’s College, Oxford with a PhD in molecular endocrinology from the University of Edinburgh.
Chris is chairman of Herbert Smith Freehills' India Practice and spends most of his time in India, a country which has become his second home. He is the guiding force behind the global Indian Practice of the firm. Having spent more than 30 years at the firm, he has over 10 years' experience of adding value to both Indian groups and to global businesses looking to invest in India. He has a deep understanding of the country and can bring this to bear for the benefit of clients.
Chris sits on the board of the UK India Business Council, the primary body that promotes business relations between the UK and India. He is ranked as a "Senior Statesman" for India by Chambers: "…he stands out as someone who is dedicated and committed to building business in India".
Chris helps guide the firm's social initiatives in India which includes HSF Bridge, a project that links law students with social causes. He was honoured in the Financial News Extra Mile awards for marking his 30 years at the firm by walking 30 marathons over 30 days across India to raise money for Indian widows. He was also included in the Financial Times Asia-Pacific Innovative Lawyer awards for his work in India including his lectures at a number of Indian Law Schools which involves an annual programme with Oxford University.
Chris has a personal interest in mental health issues not least through having suffered from depression periodically over a number of years. He was very enthusiastic about joining the Board of Trustees of MQ Mental Health.
Chris is married to Debbie and has four children.
Professor Irene Tracey
Irene is Head of Department & Nuffield Chair in Anaesthetic Science, Nuffield Department of Clinical Neurosciences at the University of Oxford. She was born in 1966 and performed her undergraduate and graduate studies in Biochemistry at the University of Oxford in Merton College. She graduated with First Class Honours, winning the Gibb’s Prize for joint top-First, and was Senior Scholar at Merton during her DPhil (PhD).
Irene held a post-doctoral position at Harvard Medical School (Martinos Imaging Centre) before returning to the UK in 1996 to help found and establish the FMRIB Centre. In 2001, she was tenured and appointed to a University Lectureship with tutorial fellowship at Christ Church at the University of Oxford. She became the Director of the FMRIB Centre in 2005 and Professor of Pain Research. In 2007 while remaining as FMRIB Director, she was elected to the Chair in Anaesthetics with Fellowship at Pembroke College.
Irene was an elected Councillor to the International Association for the Study of Pain (IASP) until 2014 and was Chair of their Scientific Program Committee for the Milan 2012 biannual world congress. In 2008, she was awarded the triennial Patrick Wall Medal from the Royal College of Anaesthetists and in 2009 was made a FRCA for her contributions to the discipline.
Irene was Deputy Chair of the UK’s Medical Research Council’s Neuroscience Mental Health Board for two years and board member from 2009-2014. She was a REF panel member for Neuroscience, Psychiatry and Psychology in 2014.
In 2015, and was elected a Fellow of the Academy of Medical Sciences. She has been Associate Head for the Medical Sciences Division since 2014. After ten years Directing the FMRIB Centre, Irene handed over the Directorship in May 2015 to Professor Heidi Johansen-Berg in order to take a one-year sabbatical prior to becoming Head of the Nuffield Department of Clinical Neurosciences in September 2016.
Irene is married to Professor Myles Allen, a climate physicist, and they have three wonderful children: a daughter, Colette, and two sons, John and Jim.